FWBI logo

First Wave BioPharma (FWBI) Accounts Payable

Annual Accounts Payable

$554.30 K
-$165.70 K-23.01%

December 31, 2023

Summary

Performance

1-Year Change

-23.01%

3-Year Change

-64.44%

5-Year Change

-74.83%

15-Year Change

-64.76%

FWBI Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$2.71 M
FWBI annual accounts payable is currently -79.53% below its historical high of $2.71 million

3-Year Low

$554.30 K
FWBI annual accounts payable is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
FWBI previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
FWBI next annual earnings announcement has not yet been scheduled

OtherFWBIbalance sheetmetrics:

Annual Accounts Receivable

-
FWBI annual accounts receivable value is unknown

Annual Total Liabilities

$3.28 M
FWBI annual total liabilities is $3.28 million

Annual Total Assets

$6.88 M
FWBI annual total assets is $6.88 million

Annual Current Assets

$4.96 M
FWBI annual total current assets is $4.96 million

Quarterly Accounts Payable

$2.00 M
+$1.44 M+260.19%

March 31, 2024

Summary

Performance

3-Month Change

+260.19%

1-Year Change

+260.19%

3-Year Change

+260.19%

5-Year Change

+260.19%

FWBI Quarterly Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$18.45 M
FWBI quarterly accounts payable is currently -89.18% below its historical high of $18.45 million

3-Year Low

$469.80 K
FWBI quarterly accounts payable is currently +324.97% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2024
FWBI previous earnings announcement was published on Mar 31, 2024

Next Quarterly Earnings Report Date

N/A
FWBI next earnings announcement has not yet been scheduled

OtherFWBIbalance sheetmetrics:

Quarterly Accounts Receivable

-
FWBI quarterly accounts receivable value is unknown

Quarterly Total Liabilities

$13.27 M
FWBI quarterly total liabilities is $13.27 million

Quarterly Total Assets

$91.13 M
FWBI quarterly total assets is $91.13 million

Quarterly Current Assets

$7.49 M
FWBI quarterly total current assets is $7.49 million

Accounts Payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

FWBI Accounts Payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-23.0%+260.2%
3 y3 years-64.4%+260.2%
5 y5 years-74.8%+260.2%

FWBI Accounts Payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-79.5%at low-49.7%-76.5%
5 y5-year-79.5%at low-89.2%-76.5%
alltimeall time-79.5%-26.1%-89.2%-79.5%

First Wave BioPharma Accounts Payable History

DateAnnualQuarterly
Mar 2024
-
$2.00 M(+260.2%)
Dec 2023
$554.30 K(-23.0%)
$554.30 K(-4.3%)
Sep 2023
-
$579.30 K(-63.6%)
Jun 2023
-
$1.59 M(+238.7%)
Mar 2023
-
$469.80 K(-34.8%)
Dec 2022
$720.00 K(-73.4%)
$720.00 K(-79.9%)
Sep 2022
-
$3.58 M(-9.7%)
Jun 2022
-
$3.97 M(+15.0%)
Mar 2022
-
$3.45 M(+27.4%)
Dec 2021
$2.71 M(+73.7%)
$2.71 M(-85.3%)
Sep 2021
-
$18.45 M(+314.6%)
Jun 2021
-
$4.45 M(+208.9%)
Mar 2021
-
$1.44 M(-7.6%)
Dec 2020
$1.56 M(-29.7%)
$1.56 M(+6.7%)
Sep 2020
-
$1.46 M(-8.6%)
Jun 2020
-
$1.60 M(+20.8%)
Mar 2020
-
$1.32 M(-40.4%)
DateAnnualQuarterly
Dec 2019
$2.22 M(+0.7%)
$2.22 M(-18.2%)
Sep 2019
-
$2.71 M(-3.1%)
Jun 2019
-
$2.80 M(-3.1%)
Mar 2019
-
$2.89 M(+31.1%)
Dec 2018
$2.20 M(+40.0%)
$2.20 M(+92.6%)
Sep 2018
-
$1.14 M(-23.2%)
Jun 2018
-
$1.49 M(+7.7%)
Mar 2018
-
$1.38 M(-12.1%)
Dec 2017
$1.57 M(+46.7%)
$1.57 M(+22.1%)
Sep 2017
-
$1.29 M(+66.6%)
Jun 2017
-
$773.00 K(-42.4%)
Mar 2017
-
$1.34 M(+25.1%)
Dec 2016
$1.07 M(+161.9%)
$1.07 M(-27.8%)
Sep 2016
-
$1.49 M(+16.9%)
Jun 2016
-
$1.27 M(+38.6%)
Mar 2016
-
$916.60 K(+123.9%)
Dec 2015
$409.40 K(-50.4%)
$409.40 K
Dec 2014
$825.60 K
-

FAQ

  • What is First Wave BioPharma annual accounts payable?
  • What is the all time high annual accounts payable for First Wave BioPharma?
  • What is First Wave BioPharma annual accounts payable year-on-year change?
  • What is First Wave BioPharma quarterly accounts payable?
  • What is the all time high quarterly accounts payable for First Wave BioPharma?
  • What is First Wave BioPharma quarterly accounts payable year-on-year change?

What is First Wave BioPharma annual accounts payable?

The current annual accounts payable of FWBI is $554.30 K

What is the all time high annual accounts payable for First Wave BioPharma?

First Wave BioPharma all-time high annual accounts payable is $2.71 M

What is First Wave BioPharma annual accounts payable year-on-year change?

Over the past year, FWBI annual accounts payable has changed by -$165.70 K (-23.01%)

What is First Wave BioPharma quarterly accounts payable?

The current quarterly accounts payable of FWBI is $2.00 M

What is the all time high quarterly accounts payable for First Wave BioPharma?

First Wave BioPharma all-time high quarterly accounts payable is $18.45 M

What is First Wave BioPharma quarterly accounts payable year-on-year change?

Over the past year, FWBI quarterly accounts payable has changed by +$1.44 M (+260.19%)